| __timestamp | ImmunityBio, Inc. | Rhythm Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 4326000 | 1213000 |
| Thursday, January 1, 2015 | 226206000 | 3425000 |
| Friday, January 1, 2016 | 94391000 | 6311000 |
| Sunday, January 1, 2017 | 53821000 | 9518000 |
| Monday, January 1, 2018 | 35463000 | 28080000 |
| Tuesday, January 1, 2019 | 46456000 | 36550000 |
| Wednesday, January 1, 2020 | 71318000 | 46125000 |
| Friday, January 1, 2021 | 135256000 | 68486000 |
| Saturday, January 1, 2022 | 102708000 | 92032000 |
| Sunday, January 1, 2023 | 129620000 | 117532000 |
Unleashing the power of data
In the competitive world of biotechnology, managing Selling, General, and Administrative (SG&A) expenses is crucial for financial health. Over the past decade, ImmunityBio, Inc. and Rhythm Pharmaceuticals, Inc. have taken different paths in optimizing these costs. From 2014 to 2023, ImmunityBio's SG&A expenses fluctuated significantly, peaking in 2015 with a staggering 2.26 times more than their 2014 expenses. Meanwhile, Rhythm Pharmaceuticals showed a more consistent increase, with their SG&A costs rising nearly 97 times from 2014 to 2023. By 2023, Rhythm Pharmaceuticals had narrowed the gap, with their expenses reaching approximately 92% of ImmunityBio's. This trend suggests a strategic shift in Rhythm's cost management, potentially positioning them for greater financial efficiency. As these companies continue to innovate, their ability to control SG&A expenses will be pivotal in sustaining growth and competitiveness.
Who Optimizes SG&A Costs Better? Vertex Pharmaceuticals Incorporated or ImmunityBio, Inc.
Breaking Down SG&A Expenses: Regeneron Pharmaceuticals, Inc. vs ImmunityBio, Inc.
Selling, General, and Administrative Costs: Takeda Pharmaceutical Company Limited vs Rhythm Pharmaceuticals, Inc.
SG&A Efficiency Analysis: Comparing BioMarin Pharmaceutical Inc. and Rhythm Pharmaceuticals, Inc.
SG&A Efficiency Analysis: Comparing CRISPR Therapeutics AG and Rhythm Pharmaceuticals, Inc.
SG&A Efficiency Analysis: Comparing Rhythm Pharmaceuticals, Inc. and PTC Therapeutics, Inc.
Rhythm Pharmaceuticals, Inc. and Vericel Corporation: SG&A Spending Patterns Compared
Rhythm Pharmaceuticals, Inc. or Travere Therapeutics, Inc.: Who Manages SG&A Costs Better?
Rhythm Pharmaceuticals, Inc. or Novavax, Inc.: Who Manages SG&A Costs Better?
SG&A Efficiency Analysis: Comparing Vericel Corporation and ImmunityBio, Inc.
SG&A Efficiency Analysis: Comparing ImmunityBio, Inc. and Supernus Pharmaceuticals, Inc.
SG&A Efficiency Analysis: Comparing ImmunityBio, Inc. and MiMedx Group, Inc.